Myriad Genetics, Inc. (MYGN) Tops Q4 EPS by 2c, FY EPS Guidance Falls Short
Get Alerts MYGN Hot Sheet
Price: $18.65 +0.27%
Financial Fact:
Income tax provision (benefit): 5.2M
Today's EPS Names:
CP, RUSHA, SEIC, More
Financial Fact:
Income tax provision (benefit): 5.2M
Today's EPS Names:
CP, RUSHA, SEIC, More
Join SI Premium – FREE
Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q4 EPS of $0.48, $0.02 better than the analyst estimate of $0.46. Revenue for the quarter came in at $188.8 million versus the consensus estimate of $187.68 million.
Myriad Genetics, Inc. sees FY2015 EPS of $1.90-$2.00, versus the consensus of $2.11. Myriad Genetics, Inc. sees FY2015 revenue of $800-820 million, versus the consensus of $815.6 million.
For earnings history and earnings-related data on Myriad Genetics, Inc. (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hasbro (HAS) brand strength sees earnings top expectations
- Knight Transportation (KNX) Misses Q1 EPS by 22c; Misses on guidance
- Century Communities (CCS) Tops Q1 EPS by 83c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!